Watch for red flags : Be wary of suspiciously low prices, unclear labeling, missing serial numbers, or incomplete documentation
Both Novo Nordisk and Eli Lilly have savings programs that aim to reduce out-of-pocket costs for weight loss drugs, regardless of whether a patient has commercial insurance coverage
Across recent clinical trials, lean soft tissue loss made up 26 to 40% of total weight lost for most GLP-1 users
Semaglutide can support patient goals by regulating appetite, reducing cravings, and improving portion control
Add The New York Post on Google *Gulp* Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January